Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Cognitive effects of topiramate in migraine patients aged 12 through 17 years.

Pandina GJ, Ness S, Polverejan E, Yuen E, Eerdekens M, Bilder RM, Ford L.

Pediatr Neurol. 2010 Mar;42(3):187-95. doi: 10.1016/j.pediatrneurol.2009.10.001.

PMID:
20159428
2.

Topiramate in migraine prevention.

Silberstein SD.

Headache. 2005 Apr;45 Suppl 1:S57-65. Review.

PMID:
15833091
3.

Topiramate in migraine prophylaxis: data from a pooled analysis and open-label extension study.

Bussone G, Usai S, D'Amico D.

Neurol Sci. 2006 May;27 Suppl 2:S159-63. Review.

PMID:
16688622
4.

Topiramate for migraine prophylaxis in pediatric patients.

Deaton TL, Mauro LS.

Ann Pharmacother. 2014 May;48(5):638-43. doi: 10.1177/1060028014521128. Epub 2014 Feb 24. Review.

PMID:
24566461
5.

Topiramate in the prevention of pediatric migraine: literature review.

Ferraro D, Di Trapani G.

J Headache Pain. 2008 Jun;9(3):147-50. doi: 10.1007/s10194-008-0030-1. Epub 2008 Apr 2. Review.

6.

Role of topiramate for the treatment of painful diabetic peripheral neuropathy.

Carroll DG, Kline KM, Malnar KF.

Pharmacotherapy. 2004 Sep;24(9):1186-93. Review.

PMID:
15460179
7.

Nervous system adverse responses to topiramate in the treatment of neuropsychiatric disorders.

Luykx JJ, Carpay JA.

Expert Opin Drug Saf. 2010 Jul;9(4):623-31. doi: 10.1517/14740331003739196. Review.

PMID:
20367527
8.

Focus on topiramate in neuropathic pain.

Dib JG.

Curr Med Res Opin. 2004 Dec;20(12):1857-61. Review.

PMID:
15701203
9.

Topiramate, pseudotumor cerebri, weight-loss and glaucoma: an ophthalmologic perspective.

Alore PL, Jay WM, Macken MP.

Semin Ophthalmol. 2006 Jan-Mar;21(1):15-7. Review.

PMID:
16517439
10.

Question 3. Topiramate for chronic migraine in children.

Jayapal S, Maheshwari N.

Arch Dis Child. 2011 Mar;96(3):318-21. doi: 10.1136/adc.2011.211151. Review. No abstract available.

PMID:
21317129
11.

Topiramate in traumatic brain injury: adverse effects on cognitive function.

Tang V, Warden J, Cullen N, Rutledge E.

J Head Trauma Rehabil. 2007 Nov-Dec;22(6):409-10. Review. No abstract available.

PMID:
18025973
12.

Topiramate in the new generation of drugs: efficacy in the treatment of alcoholic patients.

Johnson BA, Ait-Daoud N.

Curr Pharm Des. 2010;16(19):2103-12. Review.

13.

Clinical inquiries. What are the best prophylactic drugs for migraine?

Firnhaber JM, Rickett K.

J Fam Pract. 2009 Nov;58(11):608-10. Review. No abstract available.

PMID:
19891941
14.

Mitigating cognitive side effects associated with topiramate.

Antai-Otong D.

Perspect Psychiatr Care. 2005 Apr-Jun;41(2):92-3. Review. No abstract available.

PMID:
15924583
15.

Uses of topiramate in the treatment of alcohol dependence.

Johnson BA.

Expert Rev Neurother. 2004 Sep;4(5):751-8. Review.

PMID:
15853502
16.

Topiramate-induced palinopsia: a case series and review of the literature.

Yun SH, Lavin PJ, Schatz MP, Lesser RL.

J Neuroophthalmol. 2015 Jun;35(2):148-51. doi: 10.1097/WNO.0000000000000216. Review.

PMID:
25634739
17.

Effects of Topiramate on afferent visual pathways: controversies and uncertainties.

Abtahi SH, Abtahi MA, Etemadifar M, Mazloumi M, Attarzadeh H.

Neurol Sci. 2013 Apr;34(4):603-4. doi: 10.1007/s10072-012-1109-7. Epub 2012 May 19. Review. No abstract available.

PMID:
22610498
Items per page

Supplemental Content

Write to the Help Desk